AMIX

Autonomix Medical, Inc.

4.54 USD

Last updated Sep 4, 20:40 UTC

Yesterday HIGH

$4.81

Yesterday LOW

$4.31

52w HIGH

$32.55

52w LOW

$2.44

EPS

-5.02

PE

-0.90

Next Earnings

Nov 11, 2026

Overview News Government Trades Fundamentals

Autonomix Medical, Inc. stock is down -62.48% since 30 days ago. The next earnings date is Nov 11, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 September’s closed higher than August.

Henry Khederian

Tue Aug 4, 2026

Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent

Autonomix Medical is skyrocketing Tuesday after securing U.S. Patent No. 12,433,670, expanding protection for its nerve-mapping platform.
Benzinga Insights

Tue Aug 4, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares increased by
Benzinga Newsdesk

Tue Aug 4, 2026

Autonomix Medical shares are trading higher after the company announced the issuance of U.S. Patent No. 12,433,670, titled "Systems and Methods for Treating Cancer and/or Augmenting Organ Function."
Avi Kapoor

Tue Aug 4, 2026

Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings

Dow rises 1.35% with technology sector leading market gains. Pfizer beats Q2 earnings expectations. Oil down 4.2%, gold up 0.8%, European markets higher.
Benzinga Newsdesk

Tue Aug 4, 2026

Autonomix Medical Shares Halted On Circuit Breaker To The Upside, Stock Now Up 72.60%
Benzinga Newsdesk

Tue Aug 4, 2026

Autonomix Medical Granted U.S. Patent Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function'

The patent expands the Company’s intellectual property protection for technologies designed to sense, map and selectively target nerves associated with tumors, cancer-related pain, organ function and other autonomic
Benzinga Insights

Mon Aug 3, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 million. Supernus Pharmaceuticals
Benzinga Insights

Fri Jul 31, 2026

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million. BGM Group (NASDAQ:BGM) stock rose 11.63%
Benzinga Insights

Thu Jul 30, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap stands at
Benzinga Insights

Wed Jul 29, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million. SciSparc (NASDAQ:SPRC) shares